{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:35:29Z","timestamp":1779255329966,"version":"3.51.4"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"SATT Linksium","award":["160032M"],"award-info":[{"award-number":["160032M"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,12,20]]},"abstract":"<jats:p>The antifungal susceptibility tests used in clinical laboratories have several limitations. We developed a new test, SensiFONG, based on the detection of chitin levels after exposure to antifungal drugs. The optimal culture conditions were 30\u00b0C for 6\u2009h for yeast strains and 26\u00b0C for 16\u2009h for molds. The strains were exposed to a range of echinocandin or azole concentrations. Chitin was stained with calcofluor white.<\/jats:p>","DOI":"10.1128\/aac.01101-19","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T12:40:50Z","timestamp":1571834450000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["New Antifungal Susceptibility Test Based on Chitin Detection by Image Cytometry"],"prefix":"10.1128","volume":"64","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[{"name":"University Grenoble Alpes, CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC-IMAG, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arisandy N.","family":"Andriampamonjy","sequence":"additional","affiliation":[{"name":"University Grenoble Alpes, CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC-IMAG, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Bailly","sequence":"additional","affiliation":[{"name":"University Grenoble Alpes, INSERM, CHU Grenoble Alpes, HP2, Thorax and vessels, EFCR, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Garnaud","sequence":"additional","affiliation":[{"name":"University Grenoble Alpes, CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC-IMAG, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00e8le","family":"Maubon","sequence":"additional","affiliation":[{"name":"University Grenoble Alpes, CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC-IMAG, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4155-3675","authenticated-orcid":false,"given":"Muriel","family":"Cornet","sequence":"additional","affiliation":[{"name":"University Grenoble Alpes, CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC-IMAG, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4939-0367","authenticated-orcid":false,"given":"Delphine","family":"Aldebert","sequence":"additional","affiliation":[{"name":"University Grenoble Alpes, CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC-IMAG, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2007.140087"},{"key":"e_1_3_2_3_2","volume-title":"The burden of fungal disease: new evidence to show the scale of the problem across the globe","author":"Gaffi","year":"2017","unstructured":"Gaffi. 2017. The burden of fungal disease: new evidence to show the scale of the problem across the globe. Gaffi, Geneva, Switzerland."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004404"},{"key":"e_1_3_2_5_2","volume-title":"Improving outcomes for patients with fungal infections across the world a road map for the next decade","author":"Gaffi","year":"2015","unstructured":"Gaffi. 2015. Improving outcomes for patients with fungal infections across the world a road map for the next decade. Gaffi, Geneva, Switzerland."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2017.05.005"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01128-10"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30316-X"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.09.041"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2633-9"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit136"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00027-12"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00270-17"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw664"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03182-13"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.10.2"},{"key":"e_1_3_2_17_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. M27-A3, vol 28, p 6\u201312","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. M27-A3, vol 28, p 6\u201312. CLSI, Wayne, PA."},{"key":"e_1_3_2_18_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; 4th informational supplement. M27-S4, vol 32, p 28","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. 2012. Reference method for broth dilution antifungal susceptibility testing of yeasts; 4th informational supplement. M27-S4, vol 32, p 28. CLSI, Wayne, PA."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03880.x"},{"key":"e_1_3_2_20_2","unstructured":"EUCAST. 2017. Susceptibility testing of yeasts. http:\/\/www.eucast.org\/ast_of_fungi\/methodsinantifungalsusceptibilitytesting\/susceptibility_testing_of_yeasts\/."},{"key":"e_1_3_2_21_2","unstructured":"EUCAST. 2017. Susceptibility testing in moulds. http:\/\/www.eucast.org\/ast_of_fungi\/methodsinantifungalsusceptibilitytesting\/susceptibility_testing_of_moulds\/."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2014.01.001"},{"key":"e_1_3_2_23_2","unstructured":"EUCAST. 2018. Clinical breakpoints for fungi ( Candida and Aspergillus species). http:\/\/www.eucast.org\/astoffungi\/clinicalbreakpointsforantifungals\/."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.6.1383"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-010-0134-z"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3404-7"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fgb.2009.09.003"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.4489\/MYCO.2009.37.3.161"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000040"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02997.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2010.05.002"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/15.2.109"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22250"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02290-16"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/85.3.257"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.6.1.142"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01645-09"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv139"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01138-09"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01101-19","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01101-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:40:03Z","timestamp":1645479603000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01101-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12,20]]}},"alternative-id":["10.1128\/AAC.01101-19"],"URL":"https:\/\/doi.org\/10.1128\/aac.01101-19","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"2019-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01101-19"}}